Novel Frem1-Related Mouse Phenotypes and Evidence of Genetic Interactions with Gata4 and Slit3-Reference-Cited by-同舟云学术

Novel Frem1-Related Mouse Phenotypes and Evidence of Genetic Interactions with Gata4 and Slit3

Published:2013-03-11 Issue:3 Volume:8 Page:e58830
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Beck Tyler F.,Shchelochkov Oleg A.,Yu Zhiyin,Kim Bum Jun,Hernández-García Andrés,Zaveri Hitisha P.,Bishop Colin,Overbeek Paul A.,Stockton David W.,Justice Monica J.,Scott Daryl A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference64 articles.

1. The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis;I Smyth;Proc Natl Acad Sci U S A,2004

2. Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects;D Kiyozumi;Proc Natl Acad Sci U S A,2006

3. Malformation syndromes: a review of mouse/human homology;RM Winter;J Med Genet,1988

4. Fraser syndrome and mouse ‘bleb’ mutants;RM Winter;Clin Genet,1990

5. The occurence of two heritable types of abnormality among desccendants of X-rayed mice;CC Little;Am J Roentgenol,1923

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nephronectin is required to maintain right lung lobar separation during embryonic development;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-03-01

2. Frem1 activity is regulated by Sonic hedgehog signaling in the cranial neural crest mesenchyme during midfacial morphogenesis;Developmental Dynamics;2022-12-19

3. Frem1 activity regulated by Sonic Hedgehog signaling in the cranial neural crest mesenchyme guides midfacial morphogenesis;2022-07-18

4. Genetically Modified Mouse Models of Congenital Diaphragmatic Hernia: Opportunities and Limitations for Studying Altered Lung Development;Frontiers in Pediatrics;2022-05-13

5. Animal and cellular models of microphthalmia;Therapeutic Advances in Rare Disease;2021-01